StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Raised to $292 at RBC Capital
August 2, 2024 6:24 AM
RBC Capital analyst Brian Abrahams raised the price target on Biogen (NASDAQ: BIIB) to $292.00 (from $282.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Biogen (BIIB) PT Lowered to $190 at Barclays
August 2, 2024 5:56 AM
Form 10-Q BIOGEN INC. For: Jun 30
August 1, 2024 4:12 PM
Midday movers: Meta Platforms, Lilly rise; Arm, Moderna fall
August 1, 2024 8:07 AM
Biogen (BIIB) tops Q2 expectations, raises profit guidance
August 1, 2024 7:27 AM
Biogen (BIIB) Tops Q2 EPS by 127c; profit guidance raised
August 1, 2024 6:59 AM
Form 8-K BIOGEN INC. For: Aug 01
August 1, 2024 6:55 AM
Biogen lifts profit forecast, signals progress in turnaround effort
August 1, 2024 6:50 AM
Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen
July 31, 2024 9:00 AM
